Published Date: 08 Mar 2023
The so-called "meal reminder effect" can reduce the amount of food a person eats later. Researchers from the University of Cambridge studied the impact of emotions on mindful eating.
Read Full NewsThe Ebola outbreak in Congo has not yet stabilised and is still expanding as population movement fuels transmission, a World Health Organization official said on...
New data show that patients need not exercise intensely to improve outcomes.
In people living with HIV, prescription opioids alone are not linked to worse cognition or mood, but when combined with some drugs, notably antidepressants, they are associated with poorer cognition.
Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.
Patients may not know it, but obesity can lead to more headaches.
The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.
Fathers’ adverse childhood experiences are linked to a higher likelihood of their children having behavior problems.
1.
For the first time in humans, a chemotherapy drug reaches the brain.
2.
enhancing survivors of brain tumors' quality of life.
3.
In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?
4.
Fighting for others: How guilt and obligation drive desire for more intensive treatments in end-of-life cancer care
5.
Muscular strength and good physical fitness linked to lower risk of death in people with cancer
1.
Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders
2.
Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology
3.
Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology
4.
Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC
5.
Unraveling the Mysteries of Burkitt Lymphoma: A New Hope for Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Navigating the Complexities of Ph Negative ALL - Part I
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation